196 related articles for article (PubMed ID: 10508029)
1. Development of a new experimental model of penicillin-resistant Streptococcus pneumoniae pneumonia and amoxicillin treatment by reproducing human pharmacokinetics.
Piroth L; Martin L; Coulon A; Lequeu C; Duong M; Buisson M; Portier H; Chavanet P
Antimicrob Agents Chemother; 1999 Oct; 43(10):2484-92. PubMed ID: 10508029
[TBL] [Abstract][Full Text] [Related]
2. HMR 3647 human-like treatment of experimental pneumonia due to penicillin-resistant and erythromycin-resistant Streptococcus pneumoniae.
Piroth L; Desbiolles N; Mateo-Ponce V; Martin L; Lequeu C; Charles PE; Portier H; Chavanet P
J Antimicrob Chemother; 2001 Jan; 47(1):33-42. PubMed ID: 11152429
[TBL] [Abstract][Full Text] [Related]
3. Development of experimental pneumonia by infection with penicillin-insensitive Streptococcus pneumoniae in guinea pigs and their treatment with amoxicillin, cefotaxime, and meropenem.
Ponte C; Parra A; Nieto E; Soriano F
Antimicrob Agents Chemother; 1996 Dec; 40(12):2698-702. PubMed ID: 9124825
[TBL] [Abstract][Full Text] [Related]
4. Efficacies of cefotaxime and ceftriaxone in a mouse model of pneumonia induced by two penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae.
Sauve C; Azoulay-Dupuis E; Moine P; Darras-Joly C; Rieux V; Carbon C; Bédos JP
Antimicrob Agents Chemother; 1996 Dec; 40(12):2829-34. PubMed ID: 9124850
[TBL] [Abstract][Full Text] [Related]
5. Ceftaroline versus ceftriaxone in a highly penicillin-resistant pneumococcal pneumonia rabbit model using simulated human dosing.
Croisier-Bertin D; Piroth L; Charles PE; Larribeau A; Biek D; Ge Y; Chavanet P
Antimicrob Agents Chemother; 2011 Jul; 55(7):3557-63. PubMed ID: 21576444
[TBL] [Abstract][Full Text] [Related]
6. Amoxicillin is effective against penicillin-resistant Streptococcus pneumoniae strains in a mouse pneumonia model simulating human pharmacokinetics.
Abgueguen P; Azoulay-Dupuis E; Noel V; Moine P; Rieux V; Fantin B; Bedos JP
Antimicrob Agents Chemother; 2007 Jan; 51(1):208-14. PubMed ID: 17060515
[TBL] [Abstract][Full Text] [Related]
7. Synergy between amoxicillin and gentamicin in combination against a highly penicillin-resistant and -tolerant strain of Streptococcus pneumoniae in a mouse pneumonia model.
Darras-Joly C; Bédos JP; Sauve C; Moine P; Vallée E; Carbon C; Azoulay-Dupuis E
Antimicrob Agents Chemother; 1996 Sep; 40(9):2147-51. PubMed ID: 8878597
[TBL] [Abstract][Full Text] [Related]
8. Treatment of experimental pneumonia due to penicillin-resistant Streptococcus pneumoniae in immunocompetent rats.
Gavaldà J; Capdevila JA; Almirante B; Otero J; Ruiz I; Laguarda M; Allende H; Crespo E; Pigrau C; Pahissa A
Antimicrob Agents Chemother; 1997 Apr; 41(4):795-801. PubMed ID: 9087492
[TBL] [Abstract][Full Text] [Related]
9. In vivo activity and pharmacodynamics of amoxicillin in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae.
Chavanet P; Peyrard N; Pechinot A; Buisson M; Duong M; Neuwirth C; Kazmierczak A; Portier H
Antimicrob Agents Chemother; 1996 Sep; 40(9):2062-66. PubMed ID: 8878581
[TBL] [Abstract][Full Text] [Related]
10. Selection of resistant Streptococcus pneumoniae during penicillin treatment in vitro and in three animal models.
Knudsen JD; Odenholt I; Erlendsdottir H; Gottfredsson M; Cars O; Frimodt-Møller N; Espersen F; Kristinsson KG; Gudmundsson S
Antimicrob Agents Chemother; 2003 Aug; 47(8):2499-506. PubMed ID: 12878511
[TBL] [Abstract][Full Text] [Related]
11. In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia model.
Moine P; Vallée E; Azoulay-Dupuis E; Bourget P; Bédos JP; Bauchet J; Pocidalo JJ
Antimicrob Agents Chemother; 1994 Sep; 38(9):1953-8. PubMed ID: 7811003
[TBL] [Abstract][Full Text] [Related]
12. Influence of penicillin resistance on outcome in adult patients with invasive pneumococcal pneumonia: is penicillin useful against intermediately resistant strains?
Falcó V; Almirante B; Jordano Q; Calonge L; del Valle O; Pigrau C; Planes AM; Gavaldà J; Pahissa A
J Antimicrob Chemother; 2004 Aug; 54(2):481-8. PubMed ID: 15215226
[TBL] [Abstract][Full Text] [Related]
13. Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this model.
Tateda K; Takashima K; Miyazaki H; Matsumoto T; Hatori T; Yamaguchi K
Antimicrob Agents Chemother; 1996 Jun; 40(6):1520-5. PubMed ID: 8726030
[TBL] [Abstract][Full Text] [Related]
14. In vivo efficacy of a new fluoroquinolone, sparfloxacin, against penicillin-susceptible and -resistant and multiresistant strains of Streptococcus pneumoniae in a mouse model of pneumonia.
Azoulay-Dupuis E; Vallee E; Veber B; Bedos JP; Bauchet J; Pocidalo JJ
Antimicrob Agents Chemother; 1992 Dec; 36(12):2698-703. PubMed ID: 1336343
[TBL] [Abstract][Full Text] [Related]
15. Correlation between in vitro and in vivo activity of amoxicillin against Streptococcus pneumoniae in a murine pneumonia model.
Moine P; Mazoit JX; Bédos JP; Vallée E; Azoulay-Dupuis E
J Pharmacol Exp Ther; 1997 Jan; 280(1):310-5. PubMed ID: 8996211
[TBL] [Abstract][Full Text] [Related]
16. Experimental lobar pneumonia due to penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae in immunocompetent and neutropenic rats: efficacy of penicillin and teicoplanin treatment.
Candiani G; Abbondi M; Borgonovi M; Williams R
J Antimicrob Chemother; 1997 Feb; 39(2):199-207. PubMed ID: 9069540
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of a novel tetracycline derivative, glycylcycline, against penicillin-resistant Streptococcus pneumoniae in a mouse model of pneumonia.
Murakami K; Tateda K; Matsumoto T; Miyazaki S; Yamaguchi K
J Antimicrob Chemother; 2000 Oct; 46(4):629-32. PubMed ID: 11020264
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary damage and bacterial load in assessment of the efficacy of simulated human treatment-like amoxicillin (2,000 milligrams) therapy of experimental pneumococcal pneumonia caused by strains for which amoxicillin MICs differ.
Gracia M; Martínez-Marín C; Huelves L; Giménez MJ; Aguilar L; Carcas A; Ponte C; Soriano F
Antimicrob Agents Chemother; 2005 Mar; 49(3):996-1001. PubMed ID: 15728894
[TBL] [Abstract][Full Text] [Related]
19. Amoxicillin dose-effect relationship with Streptococcus pneumoniae in a mouse pneumonia model and roles of in vitro penicillin susceptibilities, autolysis, and tolerance properties of the strains.
Azoulay-Dupuis E; Moine P; Bedos JP; Rieux V; Vallee E
Antimicrob Agents Chemother; 1996 Apr; 40(4):941-6. PubMed ID: 8849256
[TBL] [Abstract][Full Text] [Related]
20. In vivo activities of amoxicillin and amoxicillin-clavulanate against Streptococcus pneumoniae: application to breakpoint determinations.
Andes D; Craig WA
Antimicrob Agents Chemother; 1998 Sep; 42(9):2375-9. PubMed ID: 9736566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]